User contributions for Weinga01

7 July 2019

• 19:5119:51, 7 July 2019 diff hist +111‎ N User:Weinga01 ‎ Created page with "Hi, I'm Anna Weingart, MD, currently a resident in Physical Medicine and Rehabilitation at New York University." current

21 May 2019

• 14:5514:55, 21 May 2019 diff hist +1‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Subgroup Analysis current
• 14:5514:55, 21 May 2019 diff hist 0‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Secondary Outcomes
• 14:5514:55, 21 May 2019 diff hist 0‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Primary Outcomes
• 14:5414:54, 21 May 2019 diff hist +19‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Baseline Characteristics
• 14:5314:53, 21 May 2019 diff hist +2‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Major Points
• 14:5314:53, 21 May 2019 diff hist +47‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Clinical Question
• 14:5114:51, 21 May 2019 diff hist −65‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Criticisms current
• 14:4714:47, 21 May 2019 diff hist +44‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Clinical Question
• 14:4614:46, 21 May 2019 diff hist +90‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Interventions
• 14:4514:45, 21 May 2019 diff hist +1‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Adverse Events
• 14:4514:45, 21 May 2019 diff hist +3‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Primary Outcomes
• 14:4414:44, 21 May 2019 diff hist +3‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Major Points
• 14:4314:43, 21 May 2019 diff hist +55‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Baseline Characteristics
• 14:4014:40, 21 May 2019 diff hist −12‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Baseline Characteristics
• 14:3314:33, 21 May 2019 diff hist −4‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Design
• 14:3214:32, 21 May 2019 diff hist −24‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Major Points
• 14:2614:26, 21 May 2019 diff hist −8‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Baseline Characteristics
• 14:2514:25, 21 May 2019 diff hist +28‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Major Points
• 14:2314:23, 21 May 2019 diff hist +19‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Major Points
• 14:2214:22, 21 May 2019 diff hist +27‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Major Points
• 14:2114:21, 21 May 2019 diff hist −2‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Major Points
• 14:2014:20, 21 May 2019 diff hist −3‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Bottom Line
• 14:2014:20, 21 May 2019 diff hist +2,643‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Major Points

17 May 2019

• 11:5711:57, 17 May 2019 diff hist +254‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Guidelines
• 11:3411:34, 17 May 2019 diff hist +5‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Funding
• 11:3411:34, 17 May 2019 diff hist −1‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Inclusion Criteria
• 11:2611:26, 17 May 2019 diff hist +82‎ A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ →‎Bottom Line

16 May 2019

• 22:1222:12, 16 May 2019 diff hist +5,224‎ N A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures ‎ Created page with "==Clinical Question== <!-- This should be a PICO (Population, Intervention, Comparison, Outcome) style question. As an example, the ACCORD trial's clinical question is shown b..."
• 22:0022:00, 16 May 2019 diff hist +13‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Baseline Characteristics
• 15:1215:12, 16 May 2019 diff hist −751‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Major Points
• 15:1015:10, 16 May 2019 diff hist +31‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Major Points
• 15:0515:05, 16 May 2019 diff hist +2‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Major Points
• 15:0115:01, 16 May 2019 diff hist 0‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Major Points
• 15:0015:00, 16 May 2019 diff hist −4‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Major Points
• 15:0015:00, 16 May 2019 diff hist −3‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Major Points
• 14:5914:59, 16 May 2019 diff hist −16‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Major Points
• 14:5814:58, 16 May 2019 diff hist +3,154‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Major Points

15 May 2019

• 18:0018:00, 15 May 2019 diff hist +31‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Baseline Characteristics
• 17:5617:56, 15 May 2019 diff hist +285‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Criticisms
• 17:5617:56, 15 May 2019 diff hist +119‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Funding
• 13:4413:44, 15 May 2019 diff hist +519‎ Placebo-controlled trial of amantadine for severe TBI ‎ →‎Outcomes

14 May 2019

• 22:1222:12, 14 May 2019 diff hist +5,526‎ N Placebo-controlled trial of amantadine for severe TBI ‎ Created page with "==Clinical Question== <!-- This should be a PICO (Population, Intervention, Comparison, Outcome) style question. As an example, the ACCORD trial's clinical question is shown b..."